Loading AI tools
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:[1]
- Difelikefalin
- Fostamatinib (trade name Tavalisse)
- Linzagolix
- Mitiglinide (Glufast)
- Remogliflozin etabonate
- Silodosin (Urief)
- Tranilast (Rizaben)
 |
 | |
| ISIN | JP3240600001 |
|---|---|
| Industry | Pharmaceutical products, therapeutic and care foods |
| Founded | August 9, 1946 |
| Headquarters | , Japan |
Key people | Mutsuo Kanzawa (CEO) |
Number of employees | 1504 |
| Website | www |
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China.[2]
Wikiwand in your browser!
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.
